CHINARES PHARMA has completed the issuance of 1.1 billion yuan corporate bonds

Zhitong
2025.10.21 10:21
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, CHINARES PHARMA announced that the first phase of its 2025 corporate bonds, with a total principal amount of RMB 1.1 billion, has been issued. The term is three years, with a coupon annual interest rate of 1.82%. The net proceeds will be used for productive expenditures, including repaying corporate debts, supplementing working capital, project development and operational expenditures, investments related to technological innovation, and other uses that comply with applicable laws and regulations

According to the Zhitong Finance APP, CHINARES PHARMA (03320) announced that the first phase of its corporate bonds for 2025, with a total principal amount of RMB 1.1 billion, has been issued. The bonds have a term of three years and a coupon annual interest rate of 1.82%. The net proceeds will be used for productive expenditures, including repaying corporate debts, replenishing working capital, project development and operational expenditures, investments related to technological innovation, and other uses that comply with applicable laws and regulations

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.